Covidien Ltd. (NYSE:COV)

CAPS Rating: 5 out of 5

The Company is in the business of developing, manufacturing and distributing medical devices and supplies, diagnostic imaging agents, pharmaceuticals and other healthcare products for use in clinical and home settings.

Recs

0
Player Avatar tahoeskibum (62.11) Submitted: 8/10/2010 10:04:48 PM : Outperform Start Price: $36.71 COV Score: +25.85

Aging boomers, M* says so, good trend

Featured Broker Partners


Advertisement